bioRxivMicrobiologyPreprint
Combinations of antifungals to effectively kill drug-resistant Candida auris
Abstract
Candida auris is an emerging, highly virulent fungal pathogen that is often resistant to multiple classes of antifungals. To overcome this resistance, we investigated the in vitro efficacy of antifungal combinations, finding that amphotericin B/micafungin resulted in drastically reduced survival (~5 logs) of all 10 isolates tested including 2 that were refractory to each individual drug. These findings suggest that combination therapy with micafungin/amphotericin B may have clinical utility against broadly resistant C. auris.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synergistic Activity of Minocycline and Rifampin in Combination with Antifungal Drugs against Candida auris
T. Brennan-Krohn, L. Friar, … J. E. Kirby·bioRxiv·Feb 23, 2021
- In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak
B. O'Brien, S. Chaturvedi, V. Chaturvedi·bioRxiv·Oct 31, 2019
- Heightened efficacy of anidulafungin when used in combination with manogepix or 5-flucytosine against Candida auris in vitro
L. L. H. John, D. D. Thomson, … E. Bignell·bioRxiv·Dec 16, 2022
- Identification and Elimination of Antifungal Tolerance in Candida auris
S. R. Koohi, S. A. Shankarnarayan, … D. A. Charlebois·bioRxiv·Dec 22, 2022
- In vivo evolution of Candida auris multi-drug resistance in a patient receiving antifungal treatment
Tristan W. Wang, Nicole E. Putnam, … Mary Ann Jabra‐Rizk·The Journal of Infectious DiseasesPeer-reviewed·Jul 29, 2025
- Antifungal efficacy of natural antiseptic products against Candida auris